This publication is linked to the following EFSA Journal article: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.8271.
openaire +1 more source
A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary. [PDF]
Tahara M +11 more
europepmc +1 more source
Levels of aripiprazole in the blood with an injection of aripiprazole administered once every two months: a plain language summary of publication. [PDF]
Wang Y +7 more
europepmc +1 more source
Plain Language Summary of the European Union One Health 2024 Zoonoses Report. [PDF]
europepmc +1 more source
Trastuzumab deruxtecan in HER2-positive advanced colorectal cancer: a plain language summary of the DESTINY-CRC02 study. [PDF]
Raghav K.
europepmc +1 more source
A plain language summary of how the body processes a lower-dose nilotinib tablet (Danziten™) compared to the existing capsule (Tasigna®). [PDF]
Mauro M, Radich J, Douer D.
europepmc +1 more source
Plain language summary of five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (liver cancer). [PDF]
Rimassa L +23 more
europepmc +1 more source
Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial. [PDF]
Allen JA +10 more
europepmc +1 more source
Plain language summary of a pain medication (liposomal bupivacaine) for pain relief after knee replacement surgery. [PDF]
Gadsden J, Gonzales J, Saha P.
europepmc +1 more source

